Naveen Goel, MD | |
6766 W Sunrise Blvd Ste 100, Plantation, FL 33313-6072 | |
(954) 583-8472 | |
(954) 583-8476 |
Full Name | Naveen Goel |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 29 Years |
Location | 6766 W Sunrise Blvd Ste 100, Plantation, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508839135 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | ME97536 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
American Access Care Of Florida, Llc | 1557466067 | 2 |
News Archive
Microglia are the first line defence of the brain and are constantly looking for infections to fight off. Overactive microglia can cause uncontrolled inflammation within the brain, which can in turn lead to neuronal damage. New research published in BioMed Central's open access journal Journal of Neuroinflammation shows that, honokiol (HNK) is able to down-regulate the production of pro-inflammatory cytokines and inflammatory enzymes in activated microglia via Klf4, a protein known to regulate DNA.
The World Bank on Monday "pledged to reroute money from other projects to provide $900 million in emergency funding to help Pakistan" with its flood recovery efforts, the New York Times reports (Ellick, 8/17).
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1 trial of VS-4718, a novel, small molecule inhibitor of focal adhesion kinase, in patients with advanced cancer.
› Verified 7 days ago
Entity Name | American Access Care Of Florida, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306998661 PECOS PAC ID: 1557466067 Enrollment ID: O20070411000405 |
News Archive
Microglia are the first line defence of the brain and are constantly looking for infections to fight off. Overactive microglia can cause uncontrolled inflammation within the brain, which can in turn lead to neuronal damage. New research published in BioMed Central's open access journal Journal of Neuroinflammation shows that, honokiol (HNK) is able to down-regulate the production of pro-inflammatory cytokines and inflammatory enzymes in activated microglia via Klf4, a protein known to regulate DNA.
The World Bank on Monday "pledged to reroute money from other projects to provide $900 million in emergency funding to help Pakistan" with its flood recovery efforts, the New York Times reports (Ellick, 8/17).
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1 trial of VS-4718, a novel, small molecule inhibitor of focal adhesion kinase, in patients with advanced cancer.
› Verified 7 days ago
Entity Name | American Access Care Of Florida Asc Llc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1528501939 PECOS PAC ID: 6800152091 Enrollment ID: O20171103000332 |
News Archive
Microglia are the first line defence of the brain and are constantly looking for infections to fight off. Overactive microglia can cause uncontrolled inflammation within the brain, which can in turn lead to neuronal damage. New research published in BioMed Central's open access journal Journal of Neuroinflammation shows that, honokiol (HNK) is able to down-regulate the production of pro-inflammatory cytokines and inflammatory enzymes in activated microglia via Klf4, a protein known to regulate DNA.
The World Bank on Monday "pledged to reroute money from other projects to provide $900 million in emergency funding to help Pakistan" with its flood recovery efforts, the New York Times reports (Ellick, 8/17).
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1 trial of VS-4718, a novel, small molecule inhibitor of focal adhesion kinase, in patients with advanced cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Naveen Goel, MD Po Box 277180, Atlanta, GA 30384-7180 Ph: (610) 644-8900 | Naveen Goel, MD 6766 W Sunrise Blvd Ste 100, Plantation, FL 33313-6072 Ph: (954) 583-8472 |
News Archive
Microglia are the first line defence of the brain and are constantly looking for infections to fight off. Overactive microglia can cause uncontrolled inflammation within the brain, which can in turn lead to neuronal damage. New research published in BioMed Central's open access journal Journal of Neuroinflammation shows that, honokiol (HNK) is able to down-regulate the production of pro-inflammatory cytokines and inflammatory enzymes in activated microglia via Klf4, a protein known to regulate DNA.
The World Bank on Monday "pledged to reroute money from other projects to provide $900 million in emergency funding to help Pakistan" with its flood recovery efforts, the New York Times reports (Ellick, 8/17).
New research findings published in the February 2016 issue of the Journal of Leukocyte Biology, suggest that a new therapeutic strategy for HIV may already be available by repurposing an existing prescription drug.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the initiation of a Phase 1 trial of VS-4718, a novel, small molecule inhibitor of focal adhesion kinase, in patients with advanced cancer.
› Verified 7 days ago
Dr. Hussein Al Dabbagh, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 8201 W Broward Blvd, Plantation, FL 33324 Phone: 954-829-0639 | |
Dr. Elliot Mark Wortzel, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 201 Nw 82 Ave, Suite 305, Plantation, FL 33324 Phone: 954-473-5303 Fax: 954-473-5406 | |
Mr. Ajaib S Mann Sr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1806 North Pine Island Rd, Plantation, FL 33322 Phone: 954-474-0110 Fax: 954-424-9859 | |
Dr. Gerardo S. Lanes, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 140 Sw 84th Ave, Suite C, Plantation, FL 33324 Phone: 954-476-9350 Fax: 954-476-2446 | |
Dr. Mohammed I Baig, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4100 S Hospital Dr, Ste 300, Plantation, FL 33317 Phone: 954-797-0601 Fax: 954-797-1466 | |
Allen Robert Sklaver, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 7353 Nw 4th St, Plantation, FL 33317 Phone: 954-584-6320 Fax: 954-587-2166 | |
Cesar Ochoa Perez, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1228 S Pine Island Rd Ste 410, Plantation, FL 33324 Phone: 954-837-1490 Fax: 954-837-1188 |